Sickle cell patients are underrepresented in clinical trials, limiting access to cutting-edge treatments. This lack of diversity hampers research progress and perpetuates healthcare inequality.
Join us in demanding that clinical trials prioritize inclusive recruitment and outreach efforts. Let’s ensure all patients have a fair chance to benefit from the latest medical breakthroughs.